Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Pandrug resistant (PDR)"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
New Microbes and New Infections, Vol 8, Iss C, Pp 166-170 (2015)
The emergence of resistance to multiple antimicrobial agents in Gram-negative bacteria is a significant threat to public health, as it restricts the armamentarium of the clinician against these infections. The aim of this study was to determine the b
Externí odkaz:
https://doaj.org/article/d543bc46b06a453d9611bfa7e1c96ae6
Autor:
Tatiana Pacheco, Rosa-Helena Bustos, Diana González, Vivian Garzón, Julio-Cesar García, Daniela Ramírez
Publikováno v:
Antibiotics, Vol 8, Iss 3, p 100 (2019)
Antimicrobial resistance to antibiotic treatment has significantly increased during recent years, causing this to become a worldwide public health problem. More than 70% of pathogenic bacteria are resistant to at least one of the currently used antib
Externí odkaz:
https://doaj.org/article/a3f0765141ac4aca830cc83dacb6002a
Autor:
Rosalino Vázquez-López, Omar Rivero Rojas, Andrea Ibarra Moreno, José Erik Urrutia Favila, Adan Peña Barreto, Guadalupe Lizeth Ortega Ortuño, Jorge Andrés Abello Vaamonde, Ivanka Alejandra Aguilar Velazco, José Marcos Félix Castro, Sandra Georgina Solano-Gálvez, Tomás Barrientos Fortes, Juan Antonio González-Barrios
Publikováno v:
Antibiotics, Vol 8, Iss 3, p 106 (2019)
Death in cancer patients can be caused by the progression of tumors, their malignity, or other associated conditions such as sepsis, which is a multiphasic host response to a pathogen that can be significantly amplified by endogenous factors. Its inc
Externí odkaz:
https://doaj.org/article/052296ac9a9747dda17c67caaa21f625
Publikováno v:
Journal of Medical Case Reports, Vol 12, Iss 1, Pp 1-5 (2018)
Journal of Medical Case Reports
Journal of Medical Case Reports
Background Acinetobacter baumannii (A. baumannii) infections are a recognized problem in healthcare, causing ventriculoperitoneal shunt infection and ventriculitis. Such infections are serious intracranial infection that can lead to serious complicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2822e7374c289d25845fb9d3f2095907
http://link.springer.com/article/10.1186/s13256-018-1680-5
http://link.springer.com/article/10.1186/s13256-018-1680-5
Autor:
José Erik Urrutia Favila, Adan Peña Barreto, Ivanka Alejandra Aguilar Velazco, Andrea Ibarra Moreno, Tomás Barrientos Fortes, José Marcos Félix Castro, Sandra Georgina Solano-Gálvez, Juan Antonio González-Barrios, Guadalupe Lizeth Ortega Ortuño, Jorge Andrés Abello Vaamonde, Rosalino Vázquez-López, Omar Rivero Rojas
Publikováno v:
Antibiotics
Antibiotics, Vol 8, Iss 3, p 106 (2019)
Antibiotics, Vol 8, Iss 3, p 106 (2019)
Death in cancer patients can be caused by the progression of tumors, their malignity, or other associated conditions such as sepsis, which is a multiphasic host response to a pathogen that can be significantly amplified by endogenous factors. Its inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::455fd6d53bbc8ce1cf3e7cda2b0fe200
http://europepmc.org/articles/PMC6783913
http://europepmc.org/articles/PMC6783913
Autor:
Diana Alejandra González, Vivian Garzón, Tatiana Pacheco, Daniela Ramírez, J. García, Rosa-Helena Bustos
Publikováno v:
Antibiotics
Antibiotics, Vol 8, Iss 3, p 100 (2019)
Antibiotics, Vol 8, Iss 3, p 100 (2019)
Antimicrobial resistance to antibiotic treatment has significantly increased during recent years, causing this to become a worldwide public health problem. More than 70% of pathogenic bacteria are resistant to at least one of the currently used antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec57f6284c1dc605d9486ab38bf04218
https://pubmed.ncbi.nlm.nih.gov/31344885
https://pubmed.ncbi.nlm.nih.gov/31344885
Autor:
Maria Beatrice Passavanti, Luca Gregorio Giaccari, Francesca Gargano, Maria Caterina Pace, Caterina Aurilio, Pasquale Sansone
Publikováno v:
Life
Life, Vol 11, Iss 474, p 474 (2021)
Life, Vol 11, Iss 474, p 474 (2021)
Background: Ceftolozane/tazobactam (C/T) is a β-lactam/β-lactamase inhibitor combination that mainly targets Gram-negative bacteria. The current international guidelines recommend including C/T treatment in the empirical therapy for hospital-acquir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0905b2d002b8d459b4ec63d19ff8366
https://doi.org/10.3390/life11060474
https://doi.org/10.3390/life11060474
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.